Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,680 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer.
Tashiro K, Kimura S, Tsuzuki S, Urabe F, Fukuokaya W, Mori K, Aikawa K, Murakami M, Sasaki H, Miki K, Miki J, Shimomura T, Yamada H, Hata K, Nishikawa H, Abe H, Watanabe K, Kimura T. Tashiro K, et al. Among authors: murakami m. Clin Genitourin Cancer. 2024 Mar 21;22(3):102075. doi: 10.1016/j.clgc.2024.102075. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38643665
Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer.
Tsuzuki S, Kawano S, Fukuokaya W, Mori K, Nishikawa H, Tashiro K, Watanabe D, Uchimoto T, Nishimura K, Yano Y, Murakami M, Koike Y, Hata K, Koide H, Miki J, Abe H, Yamada H, Naruoka T, Sugaya S, Kimura T, Tomita M, Nakajo H, Egawa S. Tsuzuki S, et al. Among authors: murakami m. Jpn J Clin Oncol. 2021 Nov 1;51(11):1665-1671. doi: 10.1093/jjco/hyab115. Jpn J Clin Oncol. 2021. PMID: 34296282
Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis.
Shimomura T, Mori K, Yasue K, Matsukawa A, Fukuokaya W, Yanagisawa T, Hata K, Murakami M, Koike Y, Miki J, Yamada H, Kimura T. Shimomura T, et al. Among authors: murakami m. Int J Clin Oncol. 2024 Feb;29(2):213-221. doi: 10.1007/s10147-023-02441-8. Epub 2023 Dec 16. Int J Clin Oncol. 2024. PMID: 38103156
Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case series.
Urabe F, Iwatani K, Hashimoto M, Suzuki H, Miyajima K, Murakami M, Tashiro K, Tsuzuki S, Furuta A, Sato S, Takahashi H, Kimura T. Urabe F, et al. Among authors: murakami m. Transl Androl Urol. 2023 Aug 31;12(8):1321-1325. doi: 10.21037/tau-23-203. Epub 2023 Aug 10. Transl Androl Urol. 2023. PMID: 37680224 Free PMC article.
Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events.
Katsuta M, Kimura T, Tashiro K, Murakami M, Hata K, Yanagisawa T, Onuma H, Yamamoto T, Sugaya S, Watanabe Y, Nobeyama Y, Egawa S, Asahina A. Katsuta M, et al. Among authors: murakami m. Anticancer Res. 2022 Apr;42(4):2023-2028. doi: 10.21873/anticanres.15682. Anticancer Res. 2022. PMID: 35347024
[A Case of Metachronous Cancer Originating from Five Different Organs].
Murakami M, Kimura T, Iwamoto M, Honda M, Ishii G, Koike Y, Sasaki H, Furuta A, Miki K, Ikegami M, Egawa S. Murakami M, et al. Hinyokika Kiyo. 2018 May;64(5):231-234. doi: 10.14989/ActaUrolJap_64_5_231. Hinyokika Kiyo. 2018. PMID: 30064163 Free article. Japanese.
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis.
Mori K, Yanagisawa T, Fukuokaya W, Iwatani K, Matsukawa A, Katayama S, Pradere B, Laukhtina E, Rajwa P, Moschini M, Albisinni S, Krajewski W, Cimadamore A, Del Giudice F, Teoh J, Urabe F, Kimura S, Murakami M, Tsuzuki S, Miki J, Miki K, Shariat SF, Kimura T; European Association of Urology-Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Mori K, et al. Among authors: murakami m. Int J Urol. 2024 Jan;31(1):25-31. doi: 10.1111/iju.15319. Epub 2023 Oct 15. Int J Urol. 2024. PMID: 37840031 Review.
[The Effect of Local Therapy on Brain Metastasis of Renal Cell Carcinoma].
Yamazaki T, Kimura T, Kayano S, Kurauchi T, Ito K, Yasue K, Onuma H, Yanagisawa T, Murakami M, Yamada H, Egawa S. Yamazaki T, et al. Among authors: murakami m. Hinyokika Kiyo. 2021 Dec;67(12):521-524. doi: 10.14989/ActaUrolJap_67_12_521. Hinyokika Kiyo. 2021. PMID: 34991291 Free article. Japanese.
Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data.
Yanagisawa T, Mori K, Matsukawa A, Kawada T, Katayama S, Bekku K, Laukhtina E, Rajwa P, Quhal F, Pradere B, Fukuokaya W, Iwatani K, Murakami M, Bensalah K, Grünwald V, Schmidinger M, Shariat SF, Kimura T. Yanagisawa T, et al. Among authors: murakami m. Cancer Immunol Immunother. 2024 Jan 30;73(2):38. doi: 10.1007/s00262-023-03621-1. Cancer Immunol Immunother. 2024. PMID: 38289361 Free PMC article. Review.
5,680 results